The following table summarizes the Company’s total outstanding borrowings (in thousands):



	Balance December 31,			Balance December 31,
Description:	2017			2016
2016 Credit Agreement - Term loan A facility (1)	$	1,429,312		$	585,000
2016 Credit Agreement - Term loan B facility (1)	496,250			—
2016 Credit Agreement - Revolving credit facility (1), (2)	595,000			115,000
Senior notes (3)	800,000			—
Other (4)	2,500			2,500
Principal amount outstanding (5), (6)	3,323,062			$	702,500
Less: deferred financing fees (7)	(44,217		)	(8,109		)
Net balance sheet carrying amount	$	3,278,845		$	694,391

(1)

The contractual annualized interest rate as of December 31, 2017 on the Term loan A and B facilities was 3.57%, which consisted of a floating Eurodollar base rate of 1.57% plus a margin of 2.00%. The contractual annualized interest rate on the revolving credit facility was 4.07%, which consisted of a floating eurodollar base rate of 1.57% plus a margin of 2.50%. However, the Company has interest rate swap contracts which effectively convert the floating eurodollar base rates on a portion of the amounts outstanding to a fixed base rate.


(2)	The Company had $558.0 million of available borrowing capacity on the revolver (not including the expansion feature) as of December 31, 2017.


(3)	Consists of an $800.0 million principal amount of Senior Notes outstanding. The Senior Notes pay a fixed rate of 5.125% and have an eight year maturity.


(4)	Consists of a $2.5 million State of Connecticut economic development loan with a 3.0% fixed rate of interest. The loan was originated in 2012 and has a 10 year maturity. Principal payments are deferred for the first five years and the loan may be repaid at any point by the Company without penalty.


(5)	The average annual interest rate on the Company's outstanding debt as of December 31, 2017 was 3.91%, including the effect of its interest rate swaps discussed below.


(6)	The contractual due dates by year on the debt outstanding as of December 31, 2017 are as follows: $80.0 million in 2018; $107.6 million in 2019; $144.7 million in 2020; $42.6 million in 2021; $1.68 billion in 2022; and approximately $1.27 billion thereafter. In January 2018 the Company repaid $255.0 million of outstandings on the revolver which were not contractually due until 2022.


(7)	The deferred financing fees are being amortized to Interest expense, net over the term of the respective debt obligation. During 2017 the Company paid $51.2 million in additional deferred financing fees and recorded a charge of approximately $6.1 million for the write-off of deferred financing fees related to the prior financing arrangement.